{
  "pmid": "36073143",
  "uid": "36073143",
  "title": "Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial.",
  "abstract": "AIMS: People with diabetes are at high risk for cardiovascular events including heart failure (HF). We examined the effect of the glucagon-like peptide 1 agonist dulaglutide on incident HF events and other cardiovascular outcomes in those with or without prior HF in the randomized placebo-controlled Researching Cardiovascular Events with a Weekly Incretin in Diabetes (REWIND) trial. METHODS AND RESULTS: The REWIND major adverse cardiovascular event (MACE) outcome was the first occurrence of a composite endpoint of non-fatal myocardial infarction, non-fatal stroke, or death from cardiovascular causes (including unknown causes). In this post-hoc analysis, a HF event was defined as an adjudication-confirmed hospitalization or urgent evaluation for HF. Of the 9901 participants studied over a median follow-up of 5.4 years, 213/4949 (4.3%) randomly assigned to dulaglutide and 226/4952 (4.6%) participants assigned to placebo experienced a HF event (hazard ratio [HR] 0.93, 95% confidence interval [CI] 0.77-1.12; p = 0.456). In the 853 (8.6%) participants with HF at baseline, there was no change in either MACE or HF events with dulaglutide as compared to participants without HF (p = 0.44 and 0.19 for interaction, respectively). Combined cardiovascular death and HF events were marginally reduced with dulaglutide compared to placebo (HR 0.88, 95% CI 0.78-1.00; p = 0.050) but unchanged in patients with and without HF at baseline (p = 0.31). CONCLUSIONS: Dulaglutide was not associated with a reduction in HF events in patients with type 2 diabetes regardless of baseline HF status over 5.4 years of follow-up.",
  "authors": [
    {
      "last_name": "Branch",
      "fore_name": "Kelley R H",
      "initials": "KRH",
      "name": "Kelley R H Branch",
      "affiliations": [
        "University of Washington Heart Institute, Seattle, WA, USA."
      ],
      "orcid": "0000-0003-2362-6498"
    },
    {
      "last_name": "Dagenais",
      "fore_name": "Gilles R",
      "initials": "GR",
      "name": "Gilles R Dagenais",
      "affiliations": [
        "Institut Universitaire de Cardiologie et Pneumologie de Québec, Université Laval, Québec City, Québec, Canada."
      ],
      "orcid": "0000-0002-4509-2004"
    },
    {
      "last_name": "Avezum",
      "fore_name": "Alvaro",
      "initials": "A",
      "name": "Alvaro Avezum",
      "affiliations": [
        "International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil."
      ],
      "orcid": "0000-0002-3073-6890"
    },
    {
      "last_name": "Basile",
      "fore_name": "Jan",
      "initials": "J",
      "name": "Jan Basile",
      "affiliations": [
        "Medical University of South Carolina, Ralph H Johnson VA Medical Center, Charleston, SC, USA."
      ],
      "orcid": "0000-0002-2302-7084"
    },
    {
      "last_name": "Conget",
      "fore_name": "Ignacio",
      "initials": "I",
      "name": "Ignacio Conget",
      "affiliations": [
        "Endocrinology and Nutrition Department, Hospital Clínic i Universitari, Barcelona, Spain."
      ],
      "orcid": "0000-0002-5532-5449"
    },
    {
      "last_name": "Cushman",
      "fore_name": "William C",
      "initials": "WC",
      "name": "William C Cushman",
      "affiliations": [
        "University of Tennessee Health Science Center, Memphis, TN, USA."
      ],
      "orcid": "0000-0001-7162-2972"
    },
    {
      "last_name": "Jansky",
      "fore_name": "Petr",
      "initials": "P",
      "name": "Petr Jansky",
      "affiliations": [
        "University Hospital Motol, Prague, Czech Republic."
      ]
    },
    {
      "last_name": "Lakshmanan",
      "fore_name": "Mark",
      "initials": "M",
      "name": "Mark Lakshmanan",
      "affiliations": [
        "Eli Lilly & Co, Indianapolis, IN, USA."
      ],
      "orcid": "0000-0002-6578-9570"
    },
    {
      "last_name": "Lanas",
      "fore_name": "Fernando",
      "initials": "F",
      "name": "Fernando Lanas",
      "affiliations": [
        "Universidad de La Fontera, Temuco, Chile."
      ],
      "orcid": "0000-0003-3595-9759"
    },
    {
      "last_name": "Leiter",
      "fore_name": "Lawrence A",
      "initials": "LA",
      "name": "Lawrence A Leiter",
      "affiliations": [
        "Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada."
      ],
      "orcid": "0000-0002-1040-6229"
    },
    {
      "last_name": "Pais",
      "fore_name": "Prem",
      "initials": "P",
      "name": "Prem Pais",
      "affiliations": [
        "St. John's Research Institute, Bangalore, India."
      ],
      "orcid": "0000-0001-5985-3137"
    },
    {
      "last_name": "Pogosova",
      "fore_name": "Nana",
      "initials": "N",
      "name": "Nana Pogosova",
      "affiliations": [
        "National Medical Research Center of Cardiology, Moscow, Russia."
      ],
      "orcid": "0000-0002-4165-804X"
    },
    {
      "last_name": "Raubenheimer",
      "fore_name": "Peter J",
      "initials": "PJ",
      "name": "Peter J Raubenheimer",
      "affiliations": [
        "Division of Endocrinology, University of Cape Town, Cape Town, South Africa."
      ],
      "orcid": "0000-0002-5416-1286"
    },
    {
      "last_name": "Ryden",
      "fore_name": "Lars",
      "initials": "L",
      "name": "Lars Ryden",
      "affiliations": [
        "Department of Medicine K2, Karolinska Institute, Stockholm, Sweden."
      ],
      "orcid": "0000-0003-3354-3063"
    },
    {
      "last_name": "Shaw",
      "fore_name": "Jonathan E",
      "initials": "JE",
      "name": "Jonathan E Shaw",
      "affiliations": [
        "Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia."
      ],
      "orcid": "0000-0002-6187-2203"
    },
    {
      "last_name": "Sheu",
      "fore_name": "Wayne H H",
      "initials": "WHH",
      "name": "Wayne H H Sheu",
      "affiliations": [
        "Division of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taipei, Taiwan."
      ],
      "orcid": "0000-0002-8805-8340"
    },
    {
      "last_name": "Temelkova-Kurktschiev",
      "fore_name": "Theodora",
      "initials": "T",
      "name": "Theodora Temelkova-Kurktschiev",
      "affiliations": [
        "Robert Koch Medical Center, Sofia, Bulgaria."
      ],
      "orcid": "0000-0002-4693-1068"
    },
    {
      "last_name": "Bethel",
      "fore_name": "M Angelyn",
      "initials": "MA",
      "name": "M Angelyn Bethel",
      "affiliations": [
        "Eli Lilly & Co, Indianapolis, IN, USA."
      ]
    },
    {
      "last_name": "Gerstein",
      "fore_name": "Hertzel C",
      "initials": "HC",
      "name": "Hertzel C Gerstein",
      "affiliations": [
        "Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada."
      ],
      "orcid": "0000-0001-8072-2836"
    },
    {
      "last_name": "Chinthanie",
      "fore_name": "Ramasundarahettige",
      "initials": "R",
      "name": "Ramasundarahettige Chinthanie",
      "affiliations": [
        "Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada."
      ]
    },
    {
      "last_name": "Probstfield",
      "fore_name": "Jeffrey L",
      "initials": "JL",
      "name": "Jeffrey L Probstfield",
      "affiliations": [
        "University of Washington Heart Institute, Seattle, WA, USA."
      ],
      "orcid": "0000-0002-4899-9971"
    }
  ],
  "journal": {
    "title": "European journal of heart failure",
    "iso_abbreviation": "Eur J Heart Fail",
    "issn": "1879-0844",
    "issn_type": "Electronic",
    "volume": "24",
    "issue": "10",
    "pub_year": "2022",
    "pub_month": "Oct"
  },
  "start_page": "1805",
  "end_page": "1812",
  "pages": "1805-1812",
  "language": "eng",
  "publication_types": [
    "Randomized Controlled Trial",
    "Journal Article",
    "Research Support, Non-U.S. Gov't"
  ],
  "keywords": [
    "Humans",
    "Diabetes Mellitus, Type 2",
    "Hypoglycemic Agents",
    "Heart Failure",
    "Treatment Outcome",
    "Incretins",
    "Cardiovascular Diseases"
  ],
  "article_ids": {
    "pubmed": "36073143",
    "doi": "10.1002/ejhf.2670"
  },
  "doi": "10.1002/ejhf.2670",
  "dates": {
    "completed": "2022-11-28",
    "revised": "2023-01-17"
  },
  "chemicals": [
    "Hypoglycemic Agents",
    "Incretins"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "current_affiliation",
    "retrieved_date": "2025-07-30T14:22:49.739257",
    "pmid": "36073143"
  }
}